Page 157 - Read Online
P. 157

Page 8 of 9                                                    Sobenin et al. Vessel Plus 2019;3:15  I  http://dx.doi.org/10.20517/2574-1209.2019.09

               lifestyle in more beneficial ecologic environment. On the other hand, it will also give a rise to earlier and
               more focused medicinal preventive measures.


               DECLARATIONS
               Authors’ contributions
               Concept of the study, general coordination and supervision of the research project, data analysis, statistical
               analysis, and draft manuscript writing: Sobenin IA
               Patients’ recruitment, clinical examination and clinical data acquisition: Myasoedova VA, Kirichenko TV,
               Orekhova VA, Grechko AV
               MtDNA genotyping: Khasanova ZB, Sinyov VV, Melnichenko AA
               Concept elaboration, general coordination and discussion: Orekhov AN

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               The study was supported by the Russian Science Foundation (19-15-00297).

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethics approval and consent to participate
               This study was kept in accordance with the Helsinki Declaration of 1975 as revised in 1983, 2008 and
               2013. It was approved by the local ethics committee of the Institute for Atherosclerosis Research, Skolkovo
               Innovation Center, Moscow, Russia. All participants gave their written informed consent prior to their
               inclusion in the study.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2019.


               REFERENCES
               1.   Marcovina SM, Crea F, Davignon J, Kaski JC, Koenig W, et al. Biochemical and bioimaging markers for risk assessment and diagnosis
                   in major cardiovascular diseases: a road to integration of complementary diagnostic tools. J Int Med 2007;261:214-34.
               2.   Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, et al. American society of echocardiography carotid intima-media thickness task
                   force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement
                   from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular
                   medicine. J Am Soc Echocardiogr 2008;21:93-111.
               3.   Amato M, Montrosi P, Ravani A, Oldani E, Galli S, et al. Carotid intima-media thickness by B-mode ultrasound as surrogate of
                   coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J
                   2007;28:2094-101.
               4.   Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, et al. Association of coronary heart disease incidence with carotid arterial
                   wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987-1993. Am J Epidemiol 1997;146:483-
                   94.
               5.   Baldassarre D, Nyyssönen K, Rauramaa R, de Faire U, Hamsten A, et al. IMPROVE study group. Cross-sectional analysis of baseline
                   data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J
                   2010;31:614-22.
               6.   D'Agostino RB, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart
                   2013;8:11-23.
               7.   Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, et al. Kuopio atherosclerosis prevention study (KAPS). A population-
   152   153   154   155   156   157   158   159   160   161   162